Design, Synthesis, and In Silico Molecular Docking Studies of Adamantanyl Hydrazinylthiazoles as Potential Antidiabetic Agents
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Sabah Siddique Choudhry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Mirpur University of Science and Technology (MUST), Mirpur, Azad Kashmir, Pakistan. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Molecular Docking Simulation, Drug Design, Thiazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Diabetes mellitus (DM) is a widespread disease that poses a major threat to millions of people. To address this issue, we have synthesized seventeen new 4‐(adamantan‐1‐yl)‐(2‐(arylidene)hydrazinyl)thiazoles ( 3a–q ) via Hantzsch synthetic approach. The molecular structures of all the compounds were confirmed using FT‐IR, 1 H‐ and 13 C‐NMR spectroscopy, and HR‐mass spectrometry. Protein kinase, α‐amylase, glycation, and oxidation inhibition potential of all compounds were also investigated, and it was found that compounds 3b , 3c , 3e–3g, and 3i–3q have shown excellent α‐amylase inhibition (IC 50 = 7.91 ± 0.07 to 28.57 ± 0.1 µM), compounds 3c , 3e , 3i , 3k, and 3p (IC 50 = 30.6 ± 0.06 to 37.8 ± 0.005 ppm) were found to be highly potent anti‐glycating agents, and compounds 3c , 3g , 3h , 3k , and 3m were found to be more potent protein kinase inhibitors as compared to standards. The compounds 3b , 3c , 3d , 3e , 3f , 3g , 3i , 3k , 3l , 3m , 3n , 3p, and 3q have shown good antioxidant potential (IC 50 = 27.5 ± 0.09 to 48.8 ± 0.09 µM) as compared to standard ascorbic acid (IC 50 = 51.3 ± 0.1 µM). The biocompatibility of all samples was also tested by employing brine shrimp lethality and in vitro hemolytic assays and was found to be safe to human erythrocytes at tested concentrations. Furthermore, the molecular docking simulation study also revealed that almost all synthesized compounds have potential interactions with target proteins at the molecular level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Mirpur University of Science and Technology (MUST), Mirpur, Azad Kashmir, Pakistan.
- Department of Chemistry and Biochemistry, Miami University, 651 E High St, Oxford, Ohio, United States.
- GSK Carbon Neutral Laboratories for Sustainable Chemistry, University of Nottingham, Nottingham, UK.
ORCID-Profile: Muhammad Haroon
Zitieren
APA
Choudhry, S. S., Mehmood, H., Akhtar, T., Haroon, M., Musa, M., & Sajid, Z. (2025). Design, Synthesis, and In Silico Molecular Docking Studies of Adamantanyl Hydrazinylthiazoles as Potential Antidiabetic Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402409
Vancouver
Choudhry SS, Mehmood H, Akhtar T, Haroon M, Musa M, Sajid Z. Design, Synthesis, and In Silico Molecular Docking Studies of Adamantanyl Hydrazinylthiazoles as Potential Antidiabetic Agents. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402409
BibTeX
@article{Choudhry2025,
author = {Choudhry, Sabah Siddique and Mehmood, Hasnain and Akhtar, Tashfeen and Haroon, Muhammad and Musa, Mustapha and Sajid, Zaroon},
title = {Design, Synthesis, and In Silico Molecular Docking Studies of Adamantanyl Hydrazinylthiazoles as Potential Antidiabetic Agents},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402409}
}
EUVIMED